| Literature DB >> 35787782 |
Belén Saavedra Cervera1,2,3, Mariana G López4, Álvaro Chiner-Oms4, Ana María García4,5, Irving Cancino-Muñoz4, Manuela Torres-Puente4, Luis Villamayor6, Carlos Madrazo-Moya4, Edson Mambuque2, Guillermo Victor Sequera3, Durval Respeito2, Silvia Blanco2, Orvalho Augusto2, Elisa López-Varela2,3, Alberto L García-Basteiro2,3,7, Iñaki Comas4,8.
Abstract
Genomic studies of the Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. To this end, we conducted a 1 year prospective surveillance-based study in Mozambique. We applied whole-genome sequencing (WGS) to 295 positive cultures. We fully characterized MTBC isolates by phylogenetics and dating evaluation, and carried out a molecular epidemiology analysis to investigate further associations with pre-defined transmission risk factors. The majority of strains (49.5%, 136/275) belonged to lineage (L) 4; 57.8 % of them (159/275) were in genomic transmission clusters (cut-off 5 SNPs), and a strikingly high proportion (45.5%) shared an identical genotype (0 SNP pairwise distance). We found two 'likely endemic' clades, comprising 67 strains, belonging to L1.2, which dated back to the late 19th century and were associated with recent spread among people living with human immunodeficiency virus (PLHIV). We describe for the first time the population structure of MTBC in our region, a high tuberculosis (TB)/HIV burden area. Clustering analysis revealed an unforeseen pattern of spread and high rates of progression to active TB, suggesting weaknesses in TB control activities. The long-term presence of local strains in Mozambique, which were responsible for large transmission among HIV/TB-coinfected patients, calls into question the role of HIV in TB transmission.Entities:
Keywords: Mycobacterium tuberculosis; genomics; molecular epidemiology; transmission; tuberculosis
Mesh:
Year: 2022 PMID: 35787782 PMCID: PMC9455694 DOI: 10.1099/mgen.0.000844
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Descriptive analysis of exploratory covariates stratified by clusters of transmission
|
Total ( |
Unclustered ( |
Clustered ( |
| |
|---|---|---|---|---|
|
|
0.583 | |||
|
<15 |
3 (1.3) |
1 (0.9) |
2 (1.7) | |
|
15–30 |
71 (31.8) |
34 (32.4) |
37 (31.6) | |
|
31–45 |
96 (43.4) |
49 (46.7) |
47 (40.2) | |
|
46–60 |
38 (17.0) |
17 (16.2) |
21 (17.9) | |
|
+60 |
14 (6.3) |
4 (3.8) |
10 (8.6) | |
|
|
6 (2.7) |
4 (3.7) |
2 (1.8) |
0.425 |
|
|
0.780 | |||
|
Female |
79 (35.4) |
36 (34.3) |
43 (36.4) | |
|
Male |
144 (64.6) |
69 (65.7) |
75 (63.6) | |
|
|
0.642 | |||
|
Negative |
58 (26.0) |
25 (23.8) |
33 (28.0) | |
|
Positive |
161 (72.2) |
77 (73.3) |
84 (71.1) | |
|
Unknown |
4 (1.8) |
3 (2.9) |
1 (0.9) | |
|
|
0.483 | |||
|
CD4 <200 cells/mm3 |
98 (60.9) |
41 (64.1) |
41 (56.9) | |
|
CD4 >200 cells/mm3 |
38 (23.6) |
23 (35.9) |
31 (43.06) | |
|
| ||||
|
Cough |
209 (93.7) |
99 (94.3) |
110 (93.2) |
0.789 |
|
Fever |
180 (80.7) |
87 (82.9) |
93 (78.8) |
0.498 |
|
Weight loss |
204 (91.8) |
98 (93.3) |
106 (89.8) |
0.472 |
|
Night sweats |
184 (82.5) |
90 (85.7) |
94 (79.7) |
0.290 |
|
Thorax pain |
73 (32.7) |
37 (35.2) |
36 (30.5) |
0.572 |
|
|
87 (52.1) |
44 (55.7) |
43 (49.9) |
0.67 |
|
|
0.925 | |||
|
Calanga |
5 (2.2) |
2 (1.9) |
3 (2.5) | |
|
Chibucutso |
4 (1.8) |
1 (1.0) |
3 (2.5) | |
|
Chibututuine |
12 (5.4) |
6 (5.8) |
6 (5.1) | |
|
Manhiça |
103 (46.4) |
46 (44.2) |
57 (48.3) | |
|
Maragra |
31 (14.0) |
16 (15.4) |
15 (12.7) | |
|
Palmeira |
28 (12.6) |
14 (13.5) |
14 (11.9) | |
|
Maluana |
13 (5.8) |
8 (7.7) |
5 (4.2) | |
|
Malavela |
10 (4.5) |
4 (3.8) |
6 (5.1) | |
|
Munguine |
7 (3.1) |
2 (1.9) |
5 (4.2) | |
|
Taninga |
9 (4.0) |
5 (4.8) |
4 (3.4) | |
|
|
21 (9.6) |
13 (12.4) |
8 (6.8) |
0.172 |
|
|
25 (11.4) |
11 (10.7) |
14 (12.1) |
0.833 |
|
|
22 (9.9) |
15 (14.8) |
7 (6.1) |
0.043 |
|
TB contact (yes)4 |
46 (26.9) |
26 (25.7) |
20 (35.7) |
0.602 |
|
Type case5 |
0.266 | |||
|
New |
186 (89.4) |
88 (88.9) |
98 (89.9) | |
|
Relapse |
13 (6.1) |
5 (5.5) |
8 (7.3) | |
|
Treatment after failure |
1 (0.05) |
0 |
1 (0.9) | |
|
Treatment after LTFU |
8 (3.8) |
6 (6.1) |
2 (1.8) | |
|
|
212 (95.1) |
100 (95.2) |
112 (94.9) |
1 |
|
|
0.336 | |||
|
High |
73 (32.7) |
33 (31.4) |
40 (34.8) | |
|
Medium |
68 (30.5) |
30 (28.8) |
38 (33.0) | |
|
Low |
47 (21.1) |
28 (26.7) |
19 (16.5) | |
|
Very low |
32 (14.3) |
14 (13.3) |
18 (15.6) | |
|
|
22 (9.9) |
12 (11.4) |
10 (8.5) |
0.505 |
|
|
3 (1.3) |
3 (1.3) |
0 |
0.102 |
|
|
4 (3.7) |
4 (3.7) |
0 |
0.0476 |
|
|
| |||
|
Cured |
122 (68.1) |
57 (69.5) |
65 (67.0) | |
|
Death |
24 (13.4) |
11 (13.4) |
13 (13.4) | |
|
Transferred |
6 (2.7) |
3 (3.7) |
3 (3.1) | |
|
Treatment completed |
11 (4.9) |
3 (3.6) |
8 (8.2) | |
|
LTFU9 |
6 (2.7) |
2 (2.4) |
4 (4.1) | |
|
Treatment failure |
10 (4.5) |
6 (7.3) |
4 (4.2) | |
|
|
0.29 | |||
|
Lineage 1.1 |
24 (11.1) |
11 (10.5) |
13 (11.0) | |
|
Lineage 1.2 |
57 (26.5) |
21 (20.0) |
36 (30.5) | |
|
Lineage 2.2 |
25 (11.6) |
8 (7.6) |
17 (14.4) | |
|
Lineage 3 |
4 (1.9) |
2 (1.9) |
2 (1.7) | |
|
Lineage 4.1 |
26 (12.1) |
13 (12.4) |
13 (11.0) | |
|
Lineage 4.3 |
49 (22.8) |
28 (26.7) |
21 (17.8) | |
|
Lineage 4.4 |
9 (4.2) |
6 (5.7) |
3 (2.5) | |
|
Lineage 4.10 |
21 (9.8) |
8 (7.6) |
13 (11.0) | |
|
Endemicity10 |
0.218 | |||
|
Yes |
54 (24.2) |
21 (20.0) |
33 (28.0) | |
|
No |
169 (75.8) |
84 (80.0) |
85 (72.0) | |
*Fisher’s-exact test. 1CD4 counts not available in 25 participants; 2X-ray not available in 56 participants; 3more than 2/3 times per week; 4six cases did not provide information; 515 responses were not available; 6R: resistant; 7MDR: multidrug resistant TB; 8information on TB outcomes not available in 44 cases; 9LTFU: lost-to-follow-up; 10endemicity defined as strains belonging to BASP clades that were estimated to have an MRCA from Mozambique (see Methods).
Multivariable logistic regression results on the association of endemicity with clustering as the outcome variable, for the entire cohort and after stratification by HIV status
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
( |
|
| ||
|
Endemic |
1.42 (0.75;2.75) |
2.19 (1.08; 4.59) |
0.033 |
0.28 (0.05;1.23) |
0.102 |
|
Non-endemic |
1 |
1 |
1 |
1aOR: best fitted multivariable regression model adjusted by sex, age group and HIV status; 2total of cases excluding mixed infections (n=8) and missing values (two HIV status unknown), 3aOR: best fitted multivariable regression model adjusted by sex and age, calculated after stratifying by HIV status; 4PLHIV: people living with HIV.
Fig. 1.Study flowchart. NTP: National Tuberculosis Programme; Xpert+: samples that tested positive by Xpert MTB/RIF; WGS: whole genome sequencing.
Fig. 2.Phylogenetic tree, 275 strains. Lineages are represented in branch colours (pink for L1, blue for L2, purple for L3 and red for L4). Twenty-five BAPS groups are denoted by different colours in the outer ring of the phylogeny.
Fig. 3.Proportion of strains linked by pairwise distance from 0 to 10 SNPs, using data from three different datasets. (a) Frequency of samples found at each pairwise distance. (b) Cumulative frequency (%) of isolates in transmission at pairwise distance from 0 to 10 SNPs. Colours: the blue line represents data from Mozambique (2013–2014), orange from Malawi (2009) and purple from Valencia (2015).
Fig. 4.Phylogeographic approach. We reconstructed a phylogeny by combining isolates from Mozambique (MZ) and 8263 genomes representative of the MTBC global genetic diversity. This was used as input to infer the origin of BAPS ancestors by RASP (R package). Following defined criteria (see Methods), we classified two large endemic clades (E) and eight foreign clades (For: non-endemic). The rest of the BAPS groups could not be classified as endemic or not. MRCA: most recent common ancestor.
Fig. 5.Endemic and non-endemic clades from L1 with BEAST dating results for the MRCA with origin in Mozambique. Pie charts represent the probability that the geographical origin of the ancestor was Mozambique (MZ). The 95 % HPD is drawn as orange intervals and refers to the ‘confidence interval’ for each ancestor estimated date. The posterior indicates the probability distribution over the parameter state space. This refers to the strength of the calculated temporal parameter. The red colour (posterior close to 1) reveals strong confidence on estimations performed for the date under the model of evolution applied. E: endemic; For: foreign (non-endemic); 95 % highest posterior density.